Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study



Cover Illustration

Client: The Lancet Infectious Diseases
               
               Issue 6, June 2025 




︎          ︎︎︎         ︎︎︎